(INOD) Innodata - Ratings and Ratios
Data Engineering, AI Training, Medical Digitization, PR Platform
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 103% |
| Value at Risk 5%th | 141% |
| Relative Tail Risk | -16.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.84 |
| Alpha | 19.37 |
| CAGR/Max DD | 2.42 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.564 |
| Beta | 2.428 |
| Beta Downside | 2.341 |
| Drawdowns 3y | |
|---|---|
| Max DD | 61.84% |
| Mean DD | 25.47% |
| Median DD | 24.05% |
Description: INOD Innodata January 15, 2026
Innodata Inc. (NASDAQ: INOD) is a data-engineering services firm operating in the U.S., U.K., Netherlands, Canada and other markets. It delivers AI-focused data preparation, annotation, model training, and deployment through its Digital Data Solutions (DDS) segment, while also offering a medical-record digitization platform (Synodex) and a marketing-communications distribution and monitoring platform (Agility). The company, founded in 1988 and headquartered in Ridgefield Park, New Jersey, trades under the Data Processing & Outsourced Services sub-industry.
Key financial signals from the most recent filing show FY 2023 revenue of roughly $122 million, up about 14 % year-over-year, with a gross margin hovering near 31 %. The DDS segment now accounts for ~68 % of total revenue, reflecting the broader industry shift toward AI training-data services, a market projected by IDC to grow at a 23 % CAGR through 2027.
Sector drivers that materially affect Innodata’s outlook include: (1) accelerating enterprise AI adoption, which fuels demand for high-quality labeled data; (2) tightening data-privacy regulations (e.g., GDPR, CCPA) that increase the need for compliant data-curation and master-data-management services; and (3) the expanding use of automated content-distribution tools in financial services and media, which underpins growth for the Agility platform.
For a deeper, data-driven assessment of Innodata’s valuation relative to peers, you may find ValueRay’s analytical dashboards useful.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 33.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.27 > 0.02 and ΔFCF/TA 14.10 > 1.0 |
| NWC/Revenue: 31.14% < 20% (prev 18.19%; Δ 12.95% < -1%) |
| CFO/TA 0.33 > 3% & CFO 51.2m > Net Income 33.6m |
| Net Debt (-69.2m) to EBITDA (46.7m): -1.48 < 3 |
| Current Ratio: 2.67 > 1.5 & < 3 |
| Outstanding Shares: last quarter (35.3m) vs 12m ago 3.70% < -2% |
| Gross Margin: 41.57% > 18% (prev 0.37%; Δ 4120 % > 0.5%) |
| Asset Turnover: 197.8% > 50% (prev 155.8%; Δ 42.00% > 0%) |
| Interest Coverage Ratio: 71.39 > 6 (EBITDA TTM 46.7m / Interest Expense TTM 577.0k) |
Altman Z'' 7.16
| A: 0.49 (Total Current Assets 118.8m - Total Current Liabilities 44.5m) / Total Assets 152.9m |
| B: 0.28 (Retained Earnings 42.3m / Total Assets 152.9m) |
| C: 0.34 (EBIT TTM 41.2m / Avg Total Assets 120.5m) |
| D: 0.73 (Book Value of Equity 40.9m / Total Liabilities 55.7m) |
| Altman-Z'' Score: 7.16 = AAA |
Beneish M -3.02
| DSRI: 0.98 (Receivables 39.4m/23.2m, Revenue 238.5m/137.4m) |
| GMI: 0.89 (GM 41.57% / 37.03%) |
| AQI: 0.51 (AQ_t 0.15 / AQ_t-1 0.29) |
| SGI: 1.74 (Revenue 238.5m / 137.4m) |
| TATA: -0.11 (NI 33.6m - CFO 51.2m) / TA 152.9m) |
| Beneish M-Score: -3.02 (Cap -4..+1) = AA |
ValueRay F-Score (Strict, 0-100) 88.72
| 1. Piotroski: 8.0pt |
| 2. FCF Yield: 2.23% |
| 3. FCF Margin: 17.07% |
| 4. Debt/Equity: 0.05 |
| 5. Debt/Ebitda: -1.48 |
| 6. ROIC - WACC: 20.10% |
| 7. RoE: 41.66% |
| 8. Revenue Trend: 91.32% |
| 9. EPS Trend: 69.91% |
What is the price of INOD shares?
Over the past week, the price has changed by -3.54%, over one month by +13.20%, over three months by -25.08% and over the past year by +79.09%.
Is INOD a buy, sell or hold?
- Strong Buy: 3
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the INOD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 93.8 | 57.7% |
| Analysts Target Price | 93.8 | 57.7% |
| ValueRay Target Price | 83.7 | 40.8% |
INOD Fundamental Data Overview January 27, 2026
P/E Forward = 43.8596
P/S = 7.9523
P/B = 19.4853
Revenue TTM = 238.5m USD
EBIT TTM = 41.2m USD
EBITDA TTM = 46.7m USD
Long Term Debt = 4.68m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 1.12m USD (from shortTermDebt, last quarter)
Debt = 4.68m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -69.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.83b USD (1.90b + Debt 4.68m - CCE 73.9m)
Interest Coverage Ratio = 71.39 (Ebit TTM 41.2m / Interest Expense TTM 577.0k)
EV/FCF = 44.90x (Enterprise Value 1.83b / FCF TTM 40.7m)
FCF Yield = 2.23% (FCF TTM 40.7m / Enterprise Value 1.83b)
FCF Margin = 17.07% (FCF TTM 40.7m / Revenue TTM 238.5m)
Net Margin = 14.11% (Net Income TTM 33.6m / Revenue TTM 238.5m)
Gross Margin = 41.57% ((Revenue TTM 238.5m - Cost of Revenue TTM 139.3m) / Revenue TTM)
Gross Margin QoQ = 41.39% (prev 39.80%)
Tobins Q-Ratio = 11.95 (Enterprise Value 1.83b / Total Assets 152.9m)
Interest Expense / Debt = 12.34% (Interest Expense 577.0k / Debt 4.68m)
Taxrate = 31.51% (3.84m / 12.2m)
NOPAT = 28.2m (EBIT 41.2m * (1 - 31.51%))
Current Ratio = 2.67 (Total Current Assets 118.8m / Total Current Liabilities 44.5m)
Debt / Equity = 0.05 (Debt 4.68m / totalStockholderEquity, last quarter 97.3m)
Debt / EBITDA = -1.48 (Net Debt -69.2m / EBITDA 46.7m)
Debt / FCF = -1.70 (Net Debt -69.2m / FCF TTM 40.7m)
Total Stockholder Equity = 80.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 27.91% (Net Income 33.6m / Total Assets 152.9m)
RoE = 41.66% (Net Income TTM 33.6m / Total Stockholder Equity 80.8m)
RoCE = 48.22% (EBIT 41.2m / Capital Employed (Equity 80.8m + L.T.Debt 4.68m))
RoIC = 34.94% (NOPAT 28.2m / Invested Capital 80.8m)
WACC = 14.84% (E(1.90b)/V(1.90b) * Re(14.86%) + D(4.68m)/V(1.90b) * Rd(12.34%) * (1-Tc(0.32)))
Discount Rate = 14.86% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 5.01%
[DCF Debug] Terminal Value 62.15% ; FCFF base≈28.8m ; Y1≈35.6m ; Y5≈60.6m
Fair Price DCF = 15.36 (EV 420.2m - Net Debt -69.2m = Equity 489.4m / Shares 31.9m; r=14.84% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 69.91 | EPS CAGR: 34.52% | SUE: -2.43 | # QB: 0
Revenue Correlation: 91.32 | Revenue CAGR: 36.85% | SUE: 0.46 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.28 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=2
EPS next Year (2026-12-31): EPS=1.28 | Chg30d=+0.000 | Revisions Net=+2 | Growth EPS=+24.9% | Growth Revenue=+25.9%
Additional Sources for INOD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle